Uncategorized
Study deems loteprednol etabonate clinically noninferior to prednisolone/fluorometholone
Loteprednol etabonate was deemed to be clinically noninferior to prednisolone acetate followed by fluorometholone taper as a topical treatment after PRK with respect to haze prevention, IOP elevation and refractive results, according to a study.